Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion

Biochemical and Biophysical Research Communications

Volumn 388, Issue 1, 2009, Pages 41-45

  Kim, Eui Tae ^a   Kim, Kyeong Kyu ^a   Matunis, Mike J ^b   Ahn, Jin Hyun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

HCMV; IE2; SIM; Sp100; SUMO; SUMO interacting motif; Ubc9

Indexed keywords

NUCLEAR PROTEIN; PROTEIN IE2; PROTEIN SP100; PROTEIN UBC9; SUMO PROTEIN; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MODIFICATION; SUMOYLATION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTIGENS, NUCLEAR; AUTOANTIGENS; CYTOMEGALOVIRUS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; UBIQUITIN-CONJUGATING ENZYMES;

HUMAN HERPESVIRUS 5;

EID: 68949158431     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.07.103     Document Type: Article

References (37)

1. Johnson E.S. Protein modification by SUMO. Annu. Rev. Biochem. 73 (2004) 355-382
2. Hay R.T. SUMO: a history of modification. Mol. Cell 18 (2005) 1-12
3. Kerscher O., Felberbaum R., and Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 22 (2006) 159-180
4. Seeler J.S., Bischof O., Nacerddine K., and Dejean A. SUMO, the three Rs and cancer. Curr. Top Microbiol. Immunol. 313 (2007) 49-71
5. Kahyo T., Nishida T., and Yasuda H. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell 8 (2001) 713-718
6. Pichler A., Gast A., Seeler J.S., Dejean A., and Melchior F. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108 (2002) 109-120
7. Kagey M.H., Melhuish T.A., and Wotton D. The polycomb protein Pc2 is a SUMO E3. Cell 113 (2003) 127-137
8. Bernier-Villamor V., Sampson D.A., Matunis M.J., and Lima C.D. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell 108 (2002) 345-356
9. Lin D., Tatham M.H., Yu B., Kim S., Hay R.T., and Chen Y. Identification of a substrate recognition site on Ubc9. J. Biol. Chem. 277 (2002) 21740-21748
10. Rodriguez M.S., Dargemont C., and Hay R.T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276 (2001) 12654-12659
11. Sampson D.A., Wang M., and Matunis M.J. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 276 (2001) 21664-21669
12. Yeh E.T., Gong L., and Kamitani T. Ubiquitin-like proteins: new wines in new bottles. Gene 248 (2000) 1-14
13. Hay R.T. SUMO-specific proteases: a twist in the tail. Trends Cell Biol. 17 (2007) 370-376
14. Boddy M.N., Howe K., Etkin L.D., Solomon E., and Freemont P.S. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene 13 (1996) 971-982
15. Kamitani T., Nguyen H.P., and Yeh E.T. Preferential modification of nuclear proteins by a novel ubiquitin-like molecule. J. Biol. Chem. 272 (1997) 14001-14004
16. Kamitani T., Kito K., Nguyen H.P., Fukuda-Kamitani T., and Yeh E.T. Characterization of a second member of the sentrin family of ubiquitin-like proteins. J. Biol. Chem. 273 (1998) 11349-11353
17. Matunis M.J., Coutavas E., and Blobel G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135 (1996) 1457-1470
18. Mahajan R., Delphin C., Guan T., Gerace L., and Melchior F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88 (1997) 97-107
19. Knipscheer P., van Dijk W.J., Olsen J.V., Mann M., and Sixma T.K. Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation. EMBO J. 26 (2007) 2797-2807
20. Capili A.D., and Lima C.D. Structure and analysis of a complex between SUMO and Ubc9 illustrates features of a conserved E2-Ubl interaction. J. Mol. Biol. 369 (2007) 608-618
21. Bencsath K.P., Podgorski M.S., Pagala V.R., Slaughter C.A., and Schulman B.A. Identification of a multifunctional binding site on Ubc9p required for Smt3p conjugation. J. Biol. Chem. 277 (2002) 47938-47945
22. Yang M., Hsu C.T., Ting C.Y., Liu L.F., and Hwang J. Assembly of a polymeric chain of SUMO1 on human topoisomerase I in vitro. J. Biol. Chem. 281 (2006) 8264-8274
23. Wohlschlegel J.A., Johnson E.S., Reed S.I., and Yates III J.R. Global analysis of protein sumoylation in Saccharomyces cerevisiae. J. Biol. Chem. 279 (2004) 45662-45668
24. Zhou W., Ryan J.J., and Zhou H. Global analyses of sumoylated proteins in Saccharomyces cerevisiae. Induction of protein sumoylation by cellular stresses. J. Biol. Chem. 279 (2004) 32262-32268
25. Denison C., Rudner A.D., Gerber S.A., Bakalarski C.E., Moazed D., and Gygi S.P. A proteomic strategy for gaining insights into protein sumoylation in yeast. Mol. Cell. Proteomics 4 (2005) 246-254
26. Hannich J.T., Lewis A., Kroetz M.B., Li S.J., Heide H., Emili A., and Hochstrasser M. Defining the SUMO-modified proteome by multiple approaches in Saccharomyces cerevisiae. J. Biol. Chem. 280 (2005) 4102-4110
27. Knipscheer P., Flotho A., Klug H., Olsen J.V., van Dijk W.J., Fish A., Johnson E.S., Mann M., Sixma T.K., and Pichler A. Ubc9 sumoylation regulates SUMO target discrimination. Mol. Cell 31 (2008) 371-382
28. Lee H.R., Kim D.J., Lee J.M., Choi C.Y., Ahn B.Y., Hayward G.S., and Ahn J.H. Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells. J. Virol. 78 (2004) 6527-6542
29. Ahn J.H., Xu Y., Jang W.J., Matunis M.J., and Hayward G.S. Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9. J. Virol. 75 (2001) 3859-3872
30. Green S., Issemann I., and Sheer E. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res. 16 (1988) 369
31. Kang H., Kim E.T., Lee H.R., Park J.J., Go Y.Y., Choi C.Y., and Ahn J.H. Inhibition of SUMO-independent PML oligomerization by the human cytomegalovirus IE1 protein. J. Gen. Virol. 87 (2006) 2181-2190
32. Huh Y.H., Kim Y.E., Kim E.T., Park J.J., Song M.J., Zhu H., Hayward G.S., and Ahn J.H. Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO. J. Virol. 82 (2008) 10444-10454
33. Shen T.H., Lin H.K., Scaglioni P.P., Yung T.M., and Pandolfi P.P. The mechanisms of PML-nuclear body formation. Mol. Cell 24 (2006) 331-339
34. Bernardi R., and Pandolfi P.P. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 8 (2007) 1006-1016
35. Hecker C.M., Rabiller M., Haglund K., Bayer P., and Dikic I. Specification of SUMO1- and SUMO2-interacting motifs. J. Biol. Chem. 281 (2006) 16117-16127
36. Minty A., Dumont X., Kaghad M., and Caput D. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J. Biol. Chem. 275 (2000) 36316-36323
37. Kerscher O. SUMO junction-what's your function? New insights through SUMO-interacting motifs. EMBO Rep. 8 (2007) 550-555